Menorrhagia in general practice — disease or illness

O’Flynn, Norma; Britten, Nicky

doi:10.1016/s0277-9536(99)00318-4

Cited by 53 publications

(74 citation statements)

References 25 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Poucos estudos avaliam a ocorrência de um distúrbio menstrual isolado. Quando isso ocorre, a maioria descreve a ocorrência de sangramento menstrual excessivo 21,23,24,25,26 , possivelmente, por esse ser o distúrbio mais frequente ou por sua presença ser mais incômoda para a mulher do que os demais distúrbios. Até onde sabem os autores, este é o primeiro estudo de base populacional realizado no país com o objetivo de investigar a prevalência de diferentes distúrbios menstruais entre mulheres de 15-54 anos de idade.…”

Section: Discussionunclassified

Distúrbios menstruais entre mulheres de 15-54 anos de idade em Pelotas, Rio Grande do Sul, Brasil: estudo de base populacional

Barcelos¹,

Zanini²,

Santos³

2013

Cad. Saúde Pública

View full text Add to dashboard Cite

A cross-sectional population-based study was conducted in Pelotas, Rio Grande do Sul State, Brazil, to 46.4% (43.3-49.4). The most prevalent disorder was heavy menstrual bleeding (23.2%; 20.5-25.8), followed by short cycle (19.2%; 16.6-21.8), long cycle (14.8%; 12.7-16.9), inter-menstrual bleeding (11.1%; 9.1-13.2), and prolonged menses (7.9%; 6.3-9.4 46,4% (43,4-49,4). O mais prevalente foi sangramento menstrual excessivo (23,2%; 20,5-25,8), seguido de ciclo menstrual curto (19,2%; 16,6-21,8), ciclo menstrual longo (14,8%; 12,7-16,9), sangramento intermenstrual (11,1%; 9,1-13,2) e menstruação prolongada (7,9%; 6,3-9,4

show abstract

Section: Discussionunclassified

Distúrbios menstruais entre mulheres de 15-54 anos de idade em Pelotas, Rio Grande do Sul, Brasil: estudo de base populacional

Barcelos¹,

Zanini²,

Santos³

2013

Cad. Saúde Pública

View full text Add to dashboard Cite

show abstract

“…95,96 Although highlighted in more recent research, 89 assessing reduction in blood volume for treatment efficacy, 97 or what reduction in menstrual blood loss is meaningful to women, 98 remains a focus of research. Higher volume of daily menstrual blood loss has been correlated with limitations in functioning and social activities.…”

Section: Comparison With Existing Workmentioning

confidence: 99%

A randomised controlled trial of the clinical effectiveness and cost-effectiveness of the levonorgestrel-releasing intrauterine system in primary care against standard treatment for menorrhagia: the ECLIPSE trial

Gupta

Daniels

Middleton

et al. 2015

Health Technol Assess

324

View full text Add to dashboard Cite

A randomised controlled trial of the clinical effectiveness and cost-effectiveness of the levonorgestrel-releasing intrauterine system in primary care against standard treatment for menorrhagia: the ECLIPSE trial Janesh K Gupta, 1,2 Jane P Daniels, 3 * Lee J Middleton, 3 Helen M Pattison, 4 Gail Prileszky, 5 Tracy E Roberts, 6 Sabina Sanghera, 6 Pelham Barton, 6 Richard Gray 7 and Joe Kai 5 on behalf of the ECLIPSE Collaborative Group This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE) (www.publicationethics.org/).Editorial contact: nihredit@southampton.ac.ukThe full HTA archive is freely available to view online at www.journalslibrary.nihr.ac.uk/hta. Print-on-demand copies can be purchased from the report pages of the NIHR Journals Library website: www.journalslibrary.nihr.ac.uk Criteria for inclusion in the Health Technology Assessment journalReports are published in Health Technology Assessment (HTA) if (1) they have resulted from work for the HTA programme, and (2) they are of a sufficiently high scientific quality as assessed by the reviewers and editors.Reviews in Health Technology Assessment are termed 'systematic' when the account of the search appraisal and synthesis methods (to minimise biases and random errors) would, in theory, permit the replication of the review by others. HTA programmeThe HTA programme, part of the National Institute for Health Research (NIHR), was set up in 1993. It produces high-quality research information on the effectiveness, costs and broader impact of health technologies for those who use, manage and provide care in the NHS. 'Health technologies' are broadly defined as all interventions used to promote health, prevent and treat disease, and improve rehabilitation and long-term care.The journal is indexed in NHS Evidence via its abstracts included in MEDLINE and its Technology Assessment Reports inform National Institute for Health and Care Excellence (NICE) guidance. HTA research is also an important source of evidence for National Screening Committee (NSC) policy decisions.For more information about the HTA programme please visit the website: http://www.nets.nihr.ac.uk/programmes/hta This reportThe research reported in this issue of the journal was funded by the HTA programme as project number 02/06/02. The contractual start date was in November 2004. The draft report began editorial review in February 2015 and was accepted for publication in May 2015. The authors have been wholly responsible for all data collection, analysis and interpretation, and for writing up their work. The HTA editors and publisher have tried to ensure the accuracy of the authors' report and would like to thank the reviewers for their constructive comments on the draft document. However, they do not accept liability for damages or losses arising from material published in this report.This report presents independent research funded by the National Institute for Health Research (NIHR). The views and opinions expressed by authors in this publicati...

show abstract

“…3 GPs have also been criticised for being dismissive of menstrual problems and not addressing patients' concerns. 4 A NICE guideline has been published recently which could lead to better primary care management of heavy menstrual bleeding and improve patients' quality of life. 5 In the past, heavy menstrual bleeding has been defined in terms of volume of menstrual blood loss.…”

Section: Heavy Menstrual Bleedingmentioning

confidence: 99%

“…Firstly, for individual women a change in volume of loss may be more significant than absolute volume of loss, for instance in leading to concern that something might be wrong or in challenging menstrual concealment strategies. 4,9 Secondly, women's ability to contain heavy loss depends on their social circumstances; for example, women in jobs without easy access to toilets may have particular difficulty in managing heavy menstrual loss. 10 Finally, it has been shown that the presence of other menstrual symptoms, such as pain, mood changes, and irregular bleeding all influence the impact of heavy menstrual bleeding.…”

Section: Heavy Menstrual Bleedingmentioning

confidence: 99%

Heavy menstrual bleeding: delivering patient-centred care

Santer¹

2008

Br J Gen Pract

View full text Add to dashboard Cite

Menorrhagia in general practice — disease or illness

Cited by 53 publications

References 25 publications

Distúrbios menstruais entre mulheres de 15-54 anos de idade em Pelotas, Rio Grande do Sul, Brasil: estudo de base populacional

Distúrbios menstruais entre mulheres de 15-54 anos de idade em Pelotas, Rio Grande do Sul, Brasil: estudo de base populacional

A randomised controlled trial of the clinical effectiveness and cost-effectiveness of the levonorgestrel-releasing intrauterine system in primary care against standard treatment for menorrhagia: the ECLIPSE trial

Heavy menstrual bleeding: delivering patient-centred care

Contact Info

Product

Resources

About